FAP and colorectal carcinoma: Early work on FAP α-targeting monoclonal antibodies investigated the toxicity, imaging, and bio-distribution of a 131-labeled monoclonal antibody (131I-mAbF19) against FAP α in patients with hepatic metastases from colorectal carcinoma.